An understanding of isoniazid (INH) drug resistance mechanism in Mycobacterium tuberculosis should provide significant insight for the development of newer anti-tubercular agents able to control INH-resistant tuberculosis (TB). The inhA-encoded 2-trans enoyl-acyl carrier protein reductase enzyme (InhA) has been shown through biochemical and genetic studies to be the primary target for INH. In agreement with these results, mutations in the inhA structural gene have been found in INH-resistant clinical isolates of M. tuberculosis, the causative agent of TB. In addition, the InhA mutants were shown to have higher dissociation constant values for NADH and lower values for the apparent first-order rate constant for INH inactivation as compared t...
AbstractTuberculosis (TB) is an ancient disease caused by Mycobacterium tuberculosis (MTB), which re...
Antimicrobial resistance represents a growing global health problem. The emergence of novel resistan...
A tuberculose, causada por Mycobacterium tuberculosis, ainda é uma emergência de saúde pública globa...
The resumption of tuberculosis led to an increased need to understand the molecular mechanisms of dr...
AbstractThe increasing prevalence of tuberculosis in many areas of the world, associated with the ri...
International audienceInhA is an enoyl-ACP reductase of Mycobacterium tuberculosis implicated in the...
Tuberculosis (TB), caused by Mycobacterium tuberculosis is a leading killer that has plagued mankind...
Isoniazid is an important antitubercular molecule identified as a drug of choice in tuberculosis tre...
Tuberculosis (TB) is a neglected disease, which continue to be major cause of morbidity and mortalit...
The resistance strains of Mycobacterium tuberculosis have complicated the tuberculosis management an...
Isoniazid, a synthetic antimicrobial agent, was found to be effective against tuberculosis in 1952 a...
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. The mycobacterial cell w...
Objectives: Enoyl acyl-carrier-protein reductase (InhA), the primary endogenous target for isoniazid...
Tuberculosis (TB) is a global health problem that affects over 10 million people. There is an urgent...
AbstractObjective/BackgroundIsoniazid (INH) is one of the effective antituberculosis (TB) drugs used...
AbstractTuberculosis (TB) is an ancient disease caused by Mycobacterium tuberculosis (MTB), which re...
Antimicrobial resistance represents a growing global health problem. The emergence of novel resistan...
A tuberculose, causada por Mycobacterium tuberculosis, ainda é uma emergência de saúde pública globa...
The resumption of tuberculosis led to an increased need to understand the molecular mechanisms of dr...
AbstractThe increasing prevalence of tuberculosis in many areas of the world, associated with the ri...
International audienceInhA is an enoyl-ACP reductase of Mycobacterium tuberculosis implicated in the...
Tuberculosis (TB), caused by Mycobacterium tuberculosis is a leading killer that has plagued mankind...
Isoniazid is an important antitubercular molecule identified as a drug of choice in tuberculosis tre...
Tuberculosis (TB) is a neglected disease, which continue to be major cause of morbidity and mortalit...
The resistance strains of Mycobacterium tuberculosis have complicated the tuberculosis management an...
Isoniazid, a synthetic antimicrobial agent, was found to be effective against tuberculosis in 1952 a...
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. The mycobacterial cell w...
Objectives: Enoyl acyl-carrier-protein reductase (InhA), the primary endogenous target for isoniazid...
Tuberculosis (TB) is a global health problem that affects over 10 million people. There is an urgent...
AbstractObjective/BackgroundIsoniazid (INH) is one of the effective antituberculosis (TB) drugs used...
AbstractTuberculosis (TB) is an ancient disease caused by Mycobacterium tuberculosis (MTB), which re...
Antimicrobial resistance represents a growing global health problem. The emergence of novel resistan...
A tuberculose, causada por Mycobacterium tuberculosis, ainda é uma emergência de saúde pública globa...